| Next 10 |
Ad
BAX News and Press Baxter International Inc.
-
Baxter boasts a broad portfolio of medically necessary products and therapies, and its brand strength is a key advantage. The company's products can be found in just about any healthcare facility from hospitals to nursing homes and beyond in over 100 countries. Due to Baxter acqui...
-
This article updates one I wrote in August 2021 based on a template article by David Van Knapp, written in June 2020. We both use the DVK Quality Snapshots scoring system to assess the quality of dividend growth stocks. The system employs five quality indicators from independent s...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips This has not been a kind year for investors. In fact, the S&P 500 fell 21% in the first half of the year. Further, on June 13 the index officially fell into bear-market territory as it closed 20% below the highs it r...
-
Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha , iTunes , Stitcher and Spotify . For further details see: Wall Street Breakfast: What Moved Markets
-
Shares of Baxter International (NYSE: BAX) were tumbling 8.8% lower as of 11:24 a.m. ET on Thursday after falling as much as 11.8% earlier in the day. The decline came after the healthcare company announced its second-quarter financial results. Baxter reported Q2 revenue of $3.7...
-
Baxter International Inc. (BAX) Q2 2022 Results Earnings Conference Call July 28, 2022, 08:30 AM ET Company Participants Clare Trachtman - Vice President, Investor Relations José Almeida - Chairman, President and Chief Executive Officer James Saccaro - ...
-
Baxter ( NYSE: BAX ) stock fell 6.8% to $62.25 in Thursday premarket trading, after the health equipment and medical device maker reported a weak set of Q2 numbers and slashed its FY 2022 sales growth and adj. EPS guidance. BAX earlier in the day posted Q2 non-GAAP E...
-
The following slide deck was published by Baxter International Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Baxter International Inc. 2022 Q2 - Results - Earnings Call Presentation
-
Baxter press release ( NYSE: BAX ): Q2 Non-GAAP EPS of $0.87 in-line. Revenue of $3.75B (+21.0% Y/Y) misses by $130M . Baxter now expects full-year 2022 sales growth to advance in the high teens on a reported basis, mid-20s on a constant currency basis and 2% to 3%...
-
Second-quarter revenue of $3.75 billion increased 21% on a reported basis, 26% on a constant currency basis and 3% on an operational basis 1 Second-quarter U.S. GAAP earnings per share (EPS) totaled $0.50; Adjusted EPS totaled $0.87 Baxter now expects full-year 2022 sales ...
Stock Information
Baxter International Inc. Company Name:
BAX Stock Symbol:
NYSE Market:
Baxter International Inc. Website:
Get BAX Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips This has not been a kind year for investors. In fact, the S&P 500 fell 21% in the first half of the year. Further, on June 13 the index officially fell into bear-market territory as it closed 20% below the highs it r...
-
Shares of Baxter International (NYSE: BAX) were tumbling 8.8% lower as of 11:24 a.m. ET on Thursday after falling as much as 11.8% earlier in the day. The decline came after the healthcare company announced its second-quarter financial results. Baxter reported Q2 revenue of $3.7...
-
Second-quarter revenue of $3.75 billion increased 21% on a reported basis, 26% on a constant currency basis and 3% on an operational basis 1 Second-quarter U.S. GAAP earnings per share (EPS) totaled $0.50; Adjusted EPS totaled $0.87 Baxter now expects full-year 2022 sales ...